Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults

NCT05377255 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Overdose

Interventions

COMBINATION_PRODUCT: 16 mg naloxone AP003
COMBINATION_PRODUCT: 8 mg naloxone NARCAN Nasal Spray

Sponsor

Emergent BioSolutions